AUS
NZ
UK
CA
USA
IND
Healthcare
Biocurious: As Mayne Pharmaceuticals faces a takeover bid, who might be next?
February 19, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Acquisition Momentum:,The agreement for Mayne Pharma to be acquired by Cosette has brought attention to the broader ASX biotech space, highlighting increased interest from global pharmaceutical companies.,Historical Perspective:,Previous...
How Are ASX-Listed Healthcare Companies Advancing Cancer Diagnostics and Treatments?
February 19, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Imagion Biosystems is leading the charge in cancer diagnostics with its MagSense platform for HER2+ breast cancer.,Noxopharm focuses on innovative treatments for glioblastoma through its Chroma platform.,Amplia and Invion are pioneering c...
Little Green Pharma Ltd (ASX:LGP) Recovery and Strategic Valuation in the Pharmaceuticals Sector
February 18, 2025 01:33 PM AEDT| By Team Kalkine MediaLittle Green Pharma Ltd (ASX:LGP) Recovery and Strategic Valuation in the Pharmaceuticals Sector
HMC Capital Considers Healthscope Acquisition with Focus on Workforce Stability
February 18, 2025 12:04 PM AEDT| By Team Kalkine MediaHighlights:,HMC Capital explores a potential acquisition of Healthscope, aiming to,maintain,operational stability.,The company,seeks,to minimise facility closures and job reductions as part of the deal.,HealthCo,Healthcare & Wellness REIT,discloses,d...
Health Check: Brokers Reduce Cochlear Valuations as Customers Delay Product Upgrades
February 18, 2025 11:00 AM AEDT| By Team Kalkine MediaBiotech Industry Update: Key Developments and Trials
Health Check: It's Time to Showcase Our Three Local Heroes
February 18, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Nanosonics prepares to introduce Coris, a new anti-infection device designed for hospital instrument cleaning.,Cogstate experiences revenue growth, driven by advancements in Alzheimer's disease clinical trials.,Sonic Healthcare reports pr...
Recce Pharmaceuticals Advances in Fight Against Skin Infections with Promising Phase II Trial Results
February 17, 2025 10:18 PM AEDT| By Team Kalkine MediaHighlights:,Positive results from Phase II trial of Recce 327 topical gel,No serious adverse events reported, meeting all safety and efficacy endpoints,Phase III trial for diabetic foot infections approved in Indonesia,Recce Pharmaceuticals (ASX:RCE)...
ASX Closes Lower as (ASX:AD8) Surges 26% and (ASX:BEN) Faces Sharp Decline
February 17, 2025 06:11 PM AEDT| By Team Kalkine MediaHighlights,(ASX:AD8) jumps 26% after strong half-year results,(,ASX:BEN,) slides 15% on weaker margins and earnings shortfall,Seven sectors end in the green, with Utilities leading gains,The Australian stock market wrapped up the trading session with...
Sonic Healthcare (ASX:SHL): A Closer Look at Stock Performance and Long-Term Outlook
February 17, 2025 04:17 PM AEDT| By Team Kalkine MediaHighlights,Sonic Healthcare (SHL) sees a 10% rise in,quarterly,share price.,Shareholder,return over the past three years shows a 23% decline.,Dividends contribute to a less negative total shareholder return (TSR) of -15%.,Sonic Healthcare (ASX:SHL),...
Recce Pharmaceuticals Shows Promising Results for Topical Gel in Treating Skin Infections, Sets Stage for Phase 3 Study
February 17, 2025 03:20 PM AEDT| By Team Kalkine MediaHighlights,Recce Pharmaceuticals’ Phase II clinical trial of its topical gel, RECCE 327 (R327G), achieved a 93% primary efficacy endpoint in treating Acute Bacterial Skin and Skin Structure Infections, including Diabetic Foot Infections.,The gel demo...
Recce Pharmaceuticals (ASX:RCE) Advances R327G to Phase III After Positive Phase II Trial Results
February 17, 2025 01:12 PM AEDT| By Team Kalkine MediaHighlights:,93% Efficacy Rate:,Recce Pharmaceuticals (ASX:RCE) reported that R327G achieved a 93% primary efficacy endpoint in its Phase II trial for bacterial skin infections.,Phase III Progress:,The company is moving forward with Phase III registra...
Althea Group’s Expansion into the North American THC Beverage Market
February 17, 2025 12:30 PM AEDT| By Team Kalkine MediaCannabis in a Can: Nanocap Althea Secures $4M to Boost THC Beverage Expansion in the US and Canada
Recce Pharmaceuticals (ASX:RCE) Advances ABSSSI Treatment with Positive Phase II Trial Results
February 17, 2025 11:30 AM AEDT| By Team Kalkine MediaBreakthrough in Infection Treatment: Recce Pharmaceuticals (ASX:RCE) Reports Strong Clinical Results
Health Check: After treating its final patient, Opthea anticipates the crucial outcomes of its make-or-break trial.
February 17, 2025 11:00 AM AEDT| By Team Kalkine MediaBiotech Developments and Market Movements in Focus
Imugene is well-funded and on the brink of revolutionizing cancer immunotherapy.
February 17, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Imugene is advancing three immunotherapy programs focused on CAR-T therapies and oncolytic viruses.,The company secured new funding through convertible notes, supporting its ongoing clinical trials.,Development of allogeneic CAR-T therapi...
Will ASX:ARX Reinvent Its Course in a Rapidly Expanding Sector?
February 16, 2025 11:30 AM AEDT| By Team Kalkine MediaHighlights,ASX:ARX experienced a sharp decline in share price, erasing earlier gains.,The company’s price-to-sales ratio remains much lower compared to many peers in biotechnology.,Recent revenue performance shows steady growth, though it lags behind...
CSL's Earnings for the First Half of 2025: EPS Falls Short of Expectations
February 16, 2025 11:30 AM AEDT| By Team Kalkine MediaHighlights:,CSL Limited (ASX:CSL) reported an increase in revenue in its latest financial results.,Earnings per share came in below expectations despite stable profit margins.,The company's stock declined over the past week amid broader market moveme...
Can Imagion Biosystems Transform HER2 Imaging for Cancer Diagnostics?
February 16, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,• MagSense HER2 imaging agent manufacturing commences for advanced clinical trials.,• Innovative imaging technology aims to enhance cancer diagnostics in the HER2+ breast cancer sector.,• Strategic steps underway to file an Investigational...
What Key Developments Define ASX:PME in Healthcare Imaging?
February 14, 2025 03:34 PM AEDT| By Team Kalkine MediaHighlights,Earnings per share growth has been robust.,Company leaders own a considerable portion of stock.,Governance practices and CEO compensation remain conservative.,The healthcare technology sector continues to evolve with advancements in diagno...
Avita Medical (ASX:AVH) Surges Over 11% on Strong Growth Outlook
February 14, 2025 02:21 PM AEDT| By Team Kalkine MediaHighlights,Avita Medical (AVH) shares,jump,over 11% following,revenue,guidance announcement.,Company,projects a 55-65% growth in,full-year,2024 commercial revenue.,Net loss widens due to increased operating expenses.,Avita Medical (ASX:AVH) saw a sha...
Advertise your brand on Kalkine Media